Patrick Gailliot
Senior Director - Patient Operations Abeona Therapeutics
Patrick has spent 22 years in the pharmaceutical and biotech industries supporting companies supplying innovative therapies to market. More recently, Patrick has worked to grow autologous manufacturing and logistics for cell and gene therapy products. Which includes leadership roles for the launch and expansion of four commercially approved therapies (Kymriah, Yescarta, Tecartus, and Zevaskyn). Starting with expanding the manufacturing network for Novartis, supporting global access internal and CDMO factories with associated supply chains. Then applying those learnings to support Kite Pharmas entering Japan and China through partnerships. Now working with clinical stage companies like BioNTech with structuring its personalized supply organization. In his current role as Senior Director of Patient Operations at Abeona Therapeutics, Patrick tackles manufacturing and logistics challenges for the companies U.S. launch and expansion of its autologous cell therapy for a rare pediatric dermatological disease
Seminars
- Facilitating technology transfer, platform standardization, and manufacturing scale-up to attain clinical and commercial readiness and enable faster market entry
- Building strategic partnerships and networks to reduce risk, shorten timelines, and improve access to global markets
- Guiding small biotech teams through the complex regulatory landscape to ensure compliance and progression toward commercialization
- Reviewing standardized shipping lanes and customs protocols to ensure timely and predictable delivery of patient-specific therapies
- Coordinating with regulatory agencies, transport services, and logistics providers to maintain safety and integrity of live-cell products in transit
- Navigating regional transport differences and compliance requirements to reduce delays, prevent product loss, and minimize risk of expiration
